Ocular Therapeutix, Inc. (OCUL)
NASDAQ: OCUL · Real-Time Price · USD
10.36
-0.46 (-4.25%)
At close: Aug 28, 2026, 4:00 PM EDT
10.45
+0.09 (0.87%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Ocular Therapeutix Employees
Ocular Therapeutix had 325 employees as of December 31, 2025. The number of employees increased by 51 or 18.61% compared to the previous year.
Employees
325
Change (1Y)
51
Growth (1Y)
18.61%
Revenue / Employee
$160,169
Profits / Employee
-$927,529
Market Cap
2.28B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 325 | 51 | 18.61% |
| Dec 31, 2024 | 274 | 7 | 2.62% |
| Dec 31, 2023 | 267 | -7 | -2.55% |
| Dec 31, 2022 | 274 | 46 | 20.18% |
| Dec 31, 2021 | 228 | 47 | 25.97% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Sarepta Therapeutics | 835 |
| Nuvation Bio | 305 |
| Harmony Biosciences Holdings | 293 |
| Biohaven | 274 |
| Kodiak Sciences | 141 |
| Aurinia Pharmaceuticals | 128 |
| Mesoblast | 108 |
| Rapport Therapeutics | 84 |
OCUL News
- 13 days ago - Clear Street sees less competition for Ocular after EyePoint miss - TheFly
- 13 days ago - Ocular Therapeutix rises 10.4% - TheFly
- 17 days ago - Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 27 days ago - Ocular Therapeutix reports Q2 EPS (35c), consensus (39c) - TheFly
- 27 days ago - Ocular Therapeutix™ Reports Second Quarter 2026 Financial Results and Business Highlights - GlobeNewsWire
- 27 days ago - Ocular Therapeutix Earnings release: Q2 2026 - Filings
- 27 days ago - Ocular Therapeutix Quarterly report: Q2 2026 - Filings
- 4 weeks ago - Ocular Therapeutix Slides: Study Result presentation - Filings